335 related articles for article (PubMed ID: 12661075)
21. Jet-vortex spray freeze drying for the production of inhalable lyophilisate powders.
Wanning S; Süverkrüp R; Lamprecht A
Eur J Pharm Sci; 2017 Jan; 96():1-7. PubMed ID: 27593988
[TBL] [Abstract][Full Text] [Related]
22. Spray drying of budesonide, formoterol fumarate and their composites-II. Statistical factorial design and in vitro deposition properties.
Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2009 Feb; 367(1-2):86-96. PubMed ID: 18929634
[TBL] [Abstract][Full Text] [Related]
23. Innovative approach to produce submicron drug particles by vibrational atomization spray drying: influence of the type of solvent and surfactant.
Durli TL; Dimer FA; Fontana MC; Pohlmann AR; Beck RC; Guterres SS
Drug Dev Ind Pharm; 2014 Aug; 40(8):1011-20. PubMed ID: 23672183
[TBL] [Abstract][Full Text] [Related]
24. Design of Inhalable Solid Dosage Forms of Budesonide and Theophylline for Pulmonary Combination Therapy.
Leng D; Kissi EO; Löbmann K; Thanki K; Fattal E; Rades T; Foged C; Yang M
AAPS PharmSciTech; 2019 Mar; 20(3):137. PubMed ID: 30847607
[TBL] [Abstract][Full Text] [Related]
25. Effect of the spraying conditions and nozzle design on the shape and size distribution of particles obtained with supercritical fluid drying.
Bouchard A; Jovanović N; de Boer AH; Martín A; Jiskoot W; Crommelin DJ; Hofland GW; Witkamp GJ
Eur J Pharm Biopharm; 2008 Sep; 70(1):389-401. PubMed ID: 18534833
[TBL] [Abstract][Full Text] [Related]
26. Development of inhalable dry powder formulation of basic fibroblast growth factor.
Ibrahim BM; Jun SW; Lee MY; Kang SH; Yeo Y
Int J Pharm; 2010 Jan; 385(1-2):66-72. PubMed ID: 19853028
[TBL] [Abstract][Full Text] [Related]
27. Entrainment of lactose inhalation powders: a study using laser diffraction.
Watling CP; Elliott JA; Cameron RE
Eur J Pharm Sci; 2010 Jul; 40(4):352-8. PubMed ID: 20417708
[TBL] [Abstract][Full Text] [Related]
28. Capreomycin inhalable powders prepared with an innovative spray-drying technique.
Schoubben A; Giovagnoli S; Tiralti MC; Blasi P; Ricci M
Int J Pharm; 2014 Jul; 469(1):132-9. PubMed ID: 24747443
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the Nano Spray Dryer B-90 for pharmaceutical applications.
Schmid K; Arpagaus C; Friess W
Pharm Dev Technol; 2011 Aug; 16(4):287-94. PubMed ID: 20491538
[TBL] [Abstract][Full Text] [Related]
30. Low-voltage electrohydrodynamic (EHD) spray drying of respirable particles.
Lastow O; Andersson J; Nilsson A; Balachandran W
Pharm Dev Technol; 2007; 12(2):175-81. PubMed ID: 17510889
[TBL] [Abstract][Full Text] [Related]
31. Colloidal transport phenomena of milk components during convective droplet drying.
Fu N; Woo MW; Chen XD
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):255-66. PubMed ID: 21703825
[TBL] [Abstract][Full Text] [Related]
32. Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation.
Liang W; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
Int J Pharm; 2018 Dec; 552(1-2):67-75. PubMed ID: 30244146
[TBL] [Abstract][Full Text] [Related]
33. Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation.
van Drooge DJ; Hinrichs WL; Dickhoff BH; Elli MN; Visser MR; Zijlstra GS; Frijlink HW
Eur J Pharm Sci; 2005 Oct; 26(2):231-40. PubMed ID: 16084699
[TBL] [Abstract][Full Text] [Related]
34. [Preparation and pharmaceutical properties of salcatonin dry powder inhalations].
Xiong LJ; Zhu JB
Yao Xue Xue Bao; 2003 Mar; 38(3):218-22. PubMed ID: 12830721
[TBL] [Abstract][Full Text] [Related]
35. Application of imaging based tools for the characterisation of hollow spray dried amorphous dispersion particles.
Gamble JF; Ferreira AP; Tobyn M; DiMemmo L; Martin K; Mathias N; Schild R; Vig B; Baumann JM; Parks S; Ashton M
Int J Pharm; 2014 Apr; 465(1-2):210-7. PubMed ID: 24508807
[TBL] [Abstract][Full Text] [Related]
36. Spray-drying nanocapsules in presence of colloidal silica as drying auxiliary agent: formulation and process variables optimization using experimental designs.
Tewa-Tagne P; Degobert G; Briançon S; Bordes C; Gauvrit JY; Lanteri P; Fessi H
Pharm Res; 2007 Apr; 24(4):650-61. PubMed ID: 17318421
[TBL] [Abstract][Full Text] [Related]
37. Relationship between surface concentration of L-leucine and bulk powder properties in spray dried formulations.
Mangal S; Meiser F; Tan G; Gengenbach T; Denman J; Rowles MR; Larson I; Morton DA
Eur J Pharm Biopharm; 2015 Aug; 94():160-9. PubMed ID: 26007290
[TBL] [Abstract][Full Text] [Related]
38. Spray-dried microparticles containing polymeric nanocapsules: formulation aspects, liquid phase interactions and particles characteristics.
Tewa-Tagne P; Briançon S; Fessi H
Int J Pharm; 2006 Nov; 325(1-2):63-74. PubMed ID: 16872767
[TBL] [Abstract][Full Text] [Related]
39. Quality by design - Spray drying of insulin intended for inhalation.
Maltesen MJ; Bjerregaard S; Hovgaard L; Havelund S; van de Weert M
Eur J Pharm Biopharm; 2008 Nov; 70(3):828-38. PubMed ID: 18755270
[TBL] [Abstract][Full Text] [Related]
40. Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats.
Onoue S; Sato H; Ogawa K; Kojo Y; Aoki Y; Kawabata Y; Wada K; Mizumoto T; Yamada S
Eur J Pharm Biopharm; 2012 Jan; 80(1):54-60. PubMed ID: 22008148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
